A Virtual Navigation Intervention to Reduce Behavioral Health Admissions From Rural Emergency Departments
NCT ID: NCT04148521
Last Updated: 2023-03-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1089 participants
INTERVENTIONAL
2019-10-14
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Behavioral Health Integration
NCT04106388
Exploratory Study Providing Telepsychiatry in the Home With a Clinician Present
NCT03854045
Integrated Telemedicine Program Evaluation
NCT07042477
The Mobile Health and Wellness Program Remote Health Study
NCT07075978
Early Transfer of Hospitalized Patients Incl. COVID-19 to a Virtual Hospital at Home Model - a Clinical Feasibility Study
NCT05087082
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Behavioral Health - Virtual Patient Navigation
All patients who meet eligibility criteria at sites where the virtual patient navigation behavioral health program is offered will be considered exposed to the intervention.
Behavioral Health - Virtual Patient Navigation
Patients are identified by a clinician in the ED as needing psychiatric evaluation and a referral is made to a tele-psych provider for a virtual consult. Patients can be enrolled to the intervention arm based on a randomization scheme that randomly allocates days that navigators are available. The psychiatrist will make a recommendation to admit or discharge the patient. For patients that have a discharge recommendation on days that BH-VPN is available, patients will be offered the BH-VPN program. Enrolled patients are followed for up to 45 days. On days where the navigator is available, all patients who meet eligibility criteria will be considered exposed to the intervention.
Usual care Behavioral Health
All patients who meet eligibility criteria at sites where the virtual patient navigator behavioral health program is not offered will be considered exposed to usual care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Health - Virtual Patient Navigation
Patients are identified by a clinician in the ED as needing psychiatric evaluation and a referral is made to a tele-psych provider for a virtual consult. Patients can be enrolled to the intervention arm based on a randomization scheme that randomly allocates days that navigators are available. The psychiatrist will make a recommendation to admit or discharge the patient. For patients that have a discharge recommendation on days that BH-VPN is available, patients will be offered the BH-VPN program. Enrolled patients are followed for up to 45 days. On days where the navigator is available, all patients who meet eligibility criteria will be considered exposed to the intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Present to an ED at participating sites
* Complete a telepsychiatric consult as captured in the electronic medical record
* Complete a telepsychiatric consult during the navigator's hours of operation
* ≥ 18 years of age at time of ED admission
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Duke Endowment
OTHER
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jason Roberge, PhD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Atrium Health - Stanly
Albemarle, North Carolina, United States
Atrium Health - Kings Mountain
Kings Mountain, North Carolina, United States
Scotland Memorial Hospital
Laurinburg, North Carolina, United States
Atrium Health - Lincoln
Lincolnton, North Carolina, United States
Carolinas HealthCare System - Blue Ridge - Morganton
Morganton, North Carolina, United States
Atrium Health - Cleveland
Shelby, North Carolina, United States
Carolinas HealthCare System - Valdese
Valdese, North Carolina, United States
Atrium Health - Anson
Wadesboro, North Carolina, United States
Columbus Regional Hospital
Whiteville, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13952
Identifier Type: OTHER
Identifier Source: secondary_id
Pro00038573
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00081746
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.